Oklahoma 2023 2023 Regular Session

Oklahoma Senate Bill SB129 Introduced / Bill

Filed 01/04/2023

                     
 
 
Req. No. 3 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
1st Session of the 59th Legislature (2023) 
 
SENATE BILL 129 	By: Bullard 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to health care; creating the 
Millstone Act of 2023 ; defining terms; prohibiting 
provision of or referral for gender transition 
procedures; providing exceptions; pro hibiting certain 
uses of public funds, public facilities , public 
employees, and state Medicaid program ; providing for 
criminal, administrative, and civil enforcement; 
authorizing certain civil actions and relief; 
providing certain construction; providing for 
codification; and declari ng an emergency. 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     NEW LAW     A new s ection of law to be codified 
in the Oklahoma Statut es as Section 2607.1 of Title 63, unless there 
is created a duplication in numbering, reads as follows: 
This act shall be known and may be cited as the Millstone Act o f 
2023. 
SECTION 2.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 2607.2 of Title 63, unless there 
is created a duplication in numbering, reads as follows: 
As used in this act:   
 
 
Req. No. 3 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
1.  “Biological sex” means the biological indication of male and 
female in the context of reproductive potentia l or capacity, such as 
sex chromosomes, naturally occurring sex hormones, gonads, and 
nonambiguous internal and external genita lia present at birth, 
without regard to an individual’s psychological, chosen, or 
subjective experience of gender; 
2.  “Cross-sex hormones” means: 
a. testosterone or other androgens given to biological 
females in amounts that are larger or more potent than 
would normally occur naturally in healt hy biological 
sex females, and 
b. estrogen given to biological males in amounts that are 
larger or more potent than would normally occur 
naturally in healthy biological sex males; 
3.  “Gender” means the psychological , behavioral, social, and 
cultural aspects of being male or female; 
4.  “Gender reassignment surgery ” means any medical or surgic al 
service that seeks to surgically alter or remove healthy physical or 
anatomical characteristics or features that are typical for the 
individual’s biological sex, in order to instill or create 
physiological or anatomical characteristics that resemble a s ex 
different from the individual ’s biological sex, including but not 
limited to genital or nongenital gender reassignment surge ry   
 
 
Req. No. 3 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
performed for the purpose of assisti ng an individual with a gender 
transition; 
5.  “Gender transition” means the process in wh ich a person goes 
from identifying with and living as a gender that corresponds to his 
or her biological sex to identifying wit h and living as a gender 
different from his or her biological sex, and may inv olve social, 
legal, or physical changes; 
6.  a. “Gender transition procedures ” means any medical or 
surgical service, including but not limited to 
physician’s services, inpatient and outpatient 
hospital services, or pr escribed drugs related to 
gender transition that seeks to: 
(1) alter or remove physica l or anatomical 
characteristics or features that are typical for 
the individual’s biological sex, or 
(2) instill or create physiological or anatomical 
characteristics that resemble a sex different 
from the individual’s biological sex, including 
but not limited to medical services that provide 
puberty-blocking drugs, cross -sex hormones, or 
other mechanisms to promote the development of 
feminizing or masculinizing features i n the 
opposite biological sex, or gen ital or nongenital 
gender reassignment surgery pe rformed for the   
 
 
Req. No. 3 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
purpose of assisting an individual with a gender 
transition. 
b. Gender transition procedures do not include: 
(1) services to persons born with a medically 
verifiable disorder of sex developme nt, including 
a person with external biological s ex 
characteristics that are irresolvably ambiguous, 
such as those born with 46 XX chromosomes with 
virilization, 46 XY chromosomes with 
undervirilization, or having both ovarian and 
testicular tissue, 
(2) services provided when a physician has otherwise 
diagnosed a disorder of sexual development that 
the physician has determined through genetic or 
biochemical testing that the person does not have 
normal sex chromosome stru cture, sex steroid 
hormone production, or sex steroid hormone 
action, 
(3) the treatment of any infection, injury, disease, 
or disorder that has been caused by or 
exacerbated by the performance of gender 
transition procedures, whether or not the gender 
transition procedure was performed in acc ordance 
with state and federal law, or   
 
 
Req. No. 3 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
(4) any procedure undertaken because the individual 
suffers from a physical disorder, physical 
injury, or physical illness that would, as 
certified by a physician, place the indivi dual in 
imminent danger of death or i mpairment of major 
bodily function unless surgery is performed; 
7.  “Genital gender reassignment surgery ” means a medical 
procedure performed for the purpose of assisting an individual with 
a gender transition, includin g but not limited to: 
a. surgical procedures such as penectomy, orchiectomy, 
vaginoplasty, clitoroplasty, or vulvoplasty for 
biologically male patients or hysterectomy or 
oophorectomy for biologically female patients, 
b. reconstruction of the fixed part of the urethra with 
or without a metoidioplasty, or 
c. phalloplasty, vaginectomy, scroto plasty, or 
implantation of erection or testicular prostheses for 
biologically female patients; 
8.  “Healthcare professional ” means a person who is licensed, 
certified, or otherwise authorized by the laws of this state to 
administer health care in the ordin ary course of the practice of his 
or her profession;   
 
 
Req. No. 3 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
9.  “Nongenital gender reassignment surgery ” means medical 
procedures performed for the purpose of assisting an indiv idual with 
a gender transition includ ing but not limited to: 
a. surgical procedures fo r biologically male patients, 
such as augmentation mammoplasty, facial feminization 
surgery, liposuction, lipofilling, voice surgery, 
thyroid cartilage reduction, gluteal augmentation, 
hair reconstruction, o r various aesthetic procedures, 
or 
b. surgical procedures for biologically female patients, 
such as subcutaneous mastectomy, voice surgery, 
liposuction, lipofilling, pectoral implants, or 
various aesthetic procedures; 
10.  “Physician” means a person who is licensed to practice 
medicine in this state; 
11. “Puberty-blocking drugs” means gonadotropin-releasing 
hormone analogues or other synthetic drugs used in biological males 
to stop luteinizing hormone secretion and ther efore testosterone 
secretion, or synthetic drugs used in biological females which stop 
the production of estrogens and progesterone, when used to delay or 
suppress pubertal development in children for the purpose of 
assisting an individual with a gender tr ansition; and 
12.  “Public funds” means state, county, or local government 
monies, in addition to any department, agency, or instrumentality   
 
 
Req. No. 3 	Page 7  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
authorized or appropriated under state law or derived from any fund 
in which such moneys are deposited. 
SECTION 3.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 2607. 3 of Title 63, unless there 
is created a duplication in numbering, reads as follows: 
A.  A physician or other healthcare professional shall not 
provide gender transition procedures to any individual under twenty-
six (26) years of age. 
B.  A physician or other healthcare professional shall not refer 
any individual under twenty-six (26) years of age to any healthcare 
professional for gender transition procedures. 
C.  A physician or other healthcare professional is not 
prohibited from providing any of the following procedures which are 
not gender transition procedures to an individual under twenty-six 
(26) years of age: 
1.  Services to persons born with a medically verifiable 
disorder of sex development, including a person with exter nal 
biological sex characteristics that are irresolvably ambiguous, such 
as those born with 46 XX chromosomes with virilization, 46 XY 
chromosomes with undervirilization, or h aving both ovarian and 
testicular tissue; 
2.  Services provided when a physician has otherwise diagnosed a 
disorder of sexual development that the physician has determined 
through genetic or biochemical testing that the person does not have   
 
 
Req. No. 3 	Page 8  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
normal sex chromosome structure, sex steroid hormone production, or 
sex steroid hormone action; 
3.  The treatment of any infection, injury, disease, or disorder 
that has been caused by or exacerbated by the performance of gender 
transition procedures, whether or not the gender transition 
procedure was performed in accordance with state and federal la w or 
whether or not funding for the gender transition procedure is 
permissible under Section 4 of this act; or 
4.  Any procedure undertaken because the individual suffers from 
a physical disorder, physical injury , or physical illness that 
would, as certified by a physician, place the individual in imminent 
danger of death or impairment of major bodily function unless 
surgery is performed. 
SECTION 4.     NEW LAW     A new section of law to be codifi ed 
in the Oklahoma Statutes as Section 2607.4 of Title 63, unless there 
is created a duplication in numbering, reads as follows: 
A.  Public funds shall not be directly or indirectly used, 
granted, paid, or distributed to a ny entity, organization, or 
individual that provides gender transition pr ocedures to an 
individual under twenty-six (26) years of age. 
B.  Healthcare services furnished in the following situations 
shall not include gender transition procedures to an indivi dual 
under twenty-six (26) years of age:   
 
 
Req. No. 3 	Page 9  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
1.  By or in a healthcare facility o wned by the state or a 
county or local government; or 
2.  By a physician or other healthcare professional employed by 
the state or a county or local government. 
C.  The state Medicaid program shall not reimburse o r provide 
coverage for gender transition procedures to an individual under 
twenty-six (26) years of age. 
SECTION 5.     NEW LAW     A new section of law to be codified 
in the Oklahoma Statutes as Section 26 07.5 of Title 63, unless there 
is created a duplication in numbering, reads as follow s: 
A.  1.  A physician or other healthcare professional found to 
have knowingly referred for or provided gender transition procedures 
to an individual under twenty-six (26) years of age shall, upon 
conviction, be guilty of a felony. 
2.  Prosecution for a criminal violation of this subsection must 
be commenced within forty (40) years after the commission of such 
offense. 
B. 1. Any referral for or provision of gender transiti on 
procedures to an individual u nder twenty-six (26) years of age is 
unprofessional conduct and shall, upon an adverse ruling by the 
appropriate licensing board, result in immediate revocation of the 
license or certificate of the physician or othe r healthcare 
professional.   
 
 
Req. No. 3 	Page 10  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
2.  Disciplinary proceedings against the physician or other 
healthcare professional must be commenced within forty (40) years 
after the commission of such offens e. 
C. 1. A person may assert a n actual or threatened violation of 
this act as a claim or defense in a j udicial or administrative 
proceeding and obtain compens atory damages, injunctive relief, 
declaratory relief, or any other appropriate relief. 
2.  A person shall bring a claim for a vi olation of this act no 
later than forty (40) years after the day the cause of action 
accrues. 
3.  An individual under eighteen (18) years of age may bring an 
action throughout their minority through a parent or next friend, 
and may bring an action in their o wn name upon reaching majority at 
any time from that point until forty (40) years after reaching the 
age of majority. 
4.  Notwithstanding any other provision of law, an action under 
this subsection may be commenced, and relief may be granted, in a 
judicial proceeding without regard to whether the person commencing 
the action has sought or exhausted available administrative 
remedies. 
5.  In any action or proceeding to enforce a provision of this 
act, a prevailing party who establishes a violation of this act 
shall recover reasonable attorney fe es.   
 
 
Req. No. 3 	Page 11  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
D.  1.  The Attorney General ma y bring an action to enforce 
compliance with this act. 
2.  This act does not deny, impair, or otherwise affect any 
right or authority of the Attorney General, this state, or any 
agency, officer, or employee of the state, acting under any law 
other than this act, to institute or intervene in any proceeding. 
SECTION 6.  It being immediately necessary for the pr eservation 
of the public peace, health or safety, an emergency is hereby 
declared to exist, by reason whereof this act shall ta ke effect and 
be in full force from and after i ts passage and approval. 
 
59-1-3 DC 1/4/2023 11:25:39 AM